Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605491666 | ||
| 003 | CHVBK | ||
| 005 | 20210128100511.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151001xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10147-015-0794-7 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10147-015-0794-7 | ||
| 245 | 0 | 0 | |a Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients |h [Elektronische Daten] |c [Tsugumi Takayama, Yuji Okura, Yoshinobu Okada, Keiichi Honma, Atsushi Nashimoto, Nobuaki Sato, Akira Yokoyama, Tohru Minamino] |
| 520 | 3 | |a Background: Neoplastic cardiac tamponade (NCT) is a life-threatening complication of cancer. The interval between cancer diagnosis and NCT onset and the prognosis after pericardiocentesis may differ according to cancer type. Methods and results: We performed a retrospective study of 113 patients (54% male) with NCT who underwent pericardiocentesis at Niigata Cancer Center Hospital between 1992 and 2013. Mean age at NCT was 61.2years (range 15.9-94.8years). The most common underlying cancers were lung cancer (59.2%), breast cancer (21.2%), lymphoma/leukemia (5.3%), and gastric/esophageal cancer (5.3%). The median time from cancer diagnosis to NCT onset was 9.0, 60.4, 5.6, and 8.0months for lung cancer, breast cancer, lymphoma/leukemia, and gastric/esophageal cancer, respectively. Kaplan-Meier survival estimates were worse for breast cancer patients with NCT than for matched breast cancer patients without NCT (P<0.0001). Median survival time after pericardiocentesis was 2.9, 4.2, 2.3, and 0.6months for lung cancer, breast cancer, lymphoma/leukemia, and gastric/esophageal cancer, respectively; one-year survival after pericardiocentesis was 6.0, 16.7, 33.3, and 0%, respectively. Conclusions: The interval between cancer diagnosis and NCT onset, the impact of NCT on prognosis, and the prognosis after pericardiocentesis differed according to cancer type. Healthcare practitioners caring for patients with NCT should recognize the differences between cancer types and customize their care accordingly. | |
| 540 | |a Japan Society of Clinical Oncology, 2015 | ||
| 690 | 7 | |a Neoplastic cardiac tamponade |2 nationallicence | |
| 690 | 7 | |a Pericardiocentesis |2 nationallicence | |
| 690 | 7 | |a Prognosis |2 nationallicence | |
| 700 | 1 | |a Takayama |D Tsugumi |u Department of Cardiology, Niigata Cancer Center Hospital, Chu-o-ku Kawagishicho 2-15-3, 951-8560, Niigata, Japan |4 aut | |
| 700 | 1 | |a Okura |D Yuji |u Department of Cardiology, Niigata Cancer Center Hospital, Chu-o-ku Kawagishicho 2-15-3, 951-8560, Niigata, Japan |4 aut | |
| 700 | 1 | |a Okada |D Yoshinobu |u Department of Internal Medicine, Kamo Hospital, Niigata, Japan |4 aut | |
| 700 | 1 | |a Honma |D Keiichi |u Department of Pathology, Niigata Cancer Center Hospital, Niigata, Japan |4 aut | |
| 700 | 1 | |a Nashimoto |D Atsushi |u Department of Digestive Surgery, Niigata Cancer Center Hospital, Niigata, Japan |4 aut | |
| 700 | 1 | |a Sato |D Nobuaki |u Department of Breast Surgery, Niigata Cancer Center Hospital, Niigata, Japan |4 aut | |
| 700 | 1 | |a Yokoyama |D Akira |u Department of Respiratory Medicine, Niigata Cancer Center Hospital, Niigata, Japan |4 aut | |
| 700 | 1 | |a Minamino |D Tohru |u Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan |4 aut | |
| 773 | 0 | |t International Journal of Clinical Oncology |d Springer Japan |g 20/5(2015-10-01), 872-877 |x 1341-9625 |q 20:5<872 |1 2015 |2 20 |o 10147 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10147-015-0794-7 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10147-015-0794-7 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Takayama |D Tsugumi |u Department of Cardiology, Niigata Cancer Center Hospital, Chu-o-ku Kawagishicho 2-15-3, 951-8560, Niigata, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Okura |D Yuji |u Department of Cardiology, Niigata Cancer Center Hospital, Chu-o-ku Kawagishicho 2-15-3, 951-8560, Niigata, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Okada |D Yoshinobu |u Department of Internal Medicine, Kamo Hospital, Niigata, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Honma |D Keiichi |u Department of Pathology, Niigata Cancer Center Hospital, Niigata, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Nashimoto |D Atsushi |u Department of Digestive Surgery, Niigata Cancer Center Hospital, Niigata, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Sato |D Nobuaki |u Department of Breast Surgery, Niigata Cancer Center Hospital, Niigata, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yokoyama |D Akira |u Department of Respiratory Medicine, Niigata Cancer Center Hospital, Niigata, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Minamino |D Tohru |u Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t International Journal of Clinical Oncology |d Springer Japan |g 20/5(2015-10-01), 872-877 |x 1341-9625 |q 20:5<872 |1 2015 |2 20 |o 10147 | ||